Get the Stockscreener App
286.49
2.21%
6.20
After Hours:
286.49
Bio Rad Laboratories Inc stock is traded at $286.49, with a volume of 173.00K.
It is up +2.21% in the last 24 hours and up +0.65% over the past month.
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
See More
Previous Close:
$280.29
Open:
$283.25
24h Volume:
173.00K
Relative Volume:
0.59
Market Cap:
$6.30B
Revenue:
$2.58B
Net Income/Loss:
$-778.69M
P/E Ratio:
-10.48
EPS:
-27.33
Net Cash Flow:
$223.75M
1W Performance:
+0.21%
1M Performance:
+0.65%
6M Performance:
+10.18%
1Y Performance:
-15.85%
1-Day Range:
$281.19
$288.15
1-Week Range:
$276.49
$288.15
52-Week Range:
$211.43
$387.99
Bio Rad Laboratories Inc Stock (BIO) Company Profile
Name
Bio Rad Laboratories Inc
Sector
Industry
Phone
(510) 724-7000
Address
1000 ALFRED NOBEL DRIVE, HERCULES
Compare BIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BIO
Bio Rad Laboratories Inc
|
286.49 | 7.59B | 2.58B | -778.69M | 223.75M | -27.33 |
|
ABT
Abbott Laboratories
|
134.57 | 233.52B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
98.23 | 145.95B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
377.84 | 144.08B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
95.59 | 121.32B | 34.20B | 4.69B | 5.30B | 3.63 |
|
EW
Edwards Lifesciences Corp
|
74.55 | 44.15B | 5.69B | 1.41B | 577.90M | 6.95 |
Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Hold |
| Apr-03-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-07-23 | Initiated | UBS | Buy |
| Jun-16-23 | Initiated | Wells Fargo | Overweight |
| Dec-07-22 | Initiated | RBC Capital Mkts | Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Jan-28-22 | Reiterated | Citigroup | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Oct-17-18 | Initiated | Goldman | Buy |
| Sep-20-18 | Initiated | Morgan Stanley | Equal-Weight |
| Feb-16-18 | Downgrade | CL King | Buy → Neutral |
| Jul-13-17 | Initiated | Wells Fargo | Outperform |
| Jun-28-17 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-18-17 | Initiated | Deutsche Bank | Hold |
| Oct-13-16 | Initiated | CL King | Buy |
| May-06-15 | Reiterated | Jefferies | Buy |
| Dec-18-09 | Initiated | Maxim Group | Buy |
| Nov-06-09 | Initiated | Jefferies & Co | Buy |
| Jul-17-09 | Initiated | Soleil | Buy |
| Sep-26-07 | Initiated | Banc of America Sec | Buy |
| Feb-23-07 | Downgrade | Robert W. Baird | Outperform → Neutral |
View All
Bio Rad Laboratories Inc Stock (BIO) Latest News
Trends Shaping the Automated Microbiology 2025-2030: Revenues to Surge by $4.65 Billion, Totalling $12.52 Billion in 2030 - GlobeNewswire Inc.
US NGS Market Forecast and Company Analysis Report - GlobeNewswire
US NGS Market Forecast and Company Analysis Report 2025-2033: Illumina, Thermo Fisher Scientific, Pacific Biosciences, QIAGEN, Roche, Bio-Rad Laboratories, Takara Bio, Hamilton, Geneious, BioMerieux - Yahoo Finance
United States Flow Cytometry Market Poised for Breakthrough - openPR.com
Value Recap: What is MDIA’s TAM (Total Addressable Market)Weekly Investment Summary & Smart Allocation Stock Tips - خودرو بانک
Bio-Rad Laboratories, Inc. $BIO Shares Sold by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC - MarketBeat
3,349 Shares in Bio-Rad Laboratories, Inc. $BIO Bought by Jacobs Levy Equity Management Inc. - MarketBeat
United Services Automobile Association Makes New $292,000 Investment in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
United States CRISPR Market Surge Fueled by Genomic Medicine & - openPR.com
What drives Bio Rad Laboratories Incs stock price2025 Fundamental Recap & Real-Time Buy Signal Alerts - خودرو بانک
Swedbank AB Decreases Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Caxton Associates LLP Takes $730,000 Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Valuation Update: Whats the RSI of Bio Rad Laboratories Inc stockForecast Cut & Free Reliable Trade Execution Plans - خودرو بانک
Acadian Asset Management LLC Boosts Stock Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Volatility Watch: Is Bio Rad Laboratories Inc a cyclical or defensive stock2025 Technical Overview & Stepwise Entry and Exit Trade Signals - خودرو بانک
Published on: 2025-09-16 13:29:49 - خودرو بانک
Bearish Setup: Will Bio Rad Laboratories Inc benefit from geopolitical trendsDividend Hike & AI Based Trade Execution Alerts - خودرو بانک
Amundi Increases Stock Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Published on: 2025-09-16 09:14:46 - خودرو بانک
Activity Recap: Is Bio Rad Laboratories Incs ROE strong enough2025 Geopolitical Influence & Reliable Price Action Trade Plans - خودرو بانک
Rally Mode: Is now the right time to enter Bio Rad Laboratories Inc2025 Earnings Impact & Fast Gain Stock Tips - خودرو بانک
Bio-Rad Launches EZ-Check Salmonella Kit - Quality Assurance & Food Safety
Retail Trends: What are Bio Rad Laboratories Inc.’s earnings expectations2025 Fundamental Recap & Daily Chart Pattern Signals - خودرو بانک
Earnings Beat: What is the long term forecast for Bio Rad Laboratories Inc stockTake Profit & Free Daily Entry Point Trade Alerts - خودرو بانک
US Drug Abuse Testing Market Forecast and Company Analysis Report 2025-2033 Featuring Danaher, LabCorp, Abbott, Quest Diagnostics, Thermo Fisher Scientific, F. Hoffmann-La Roche, Bio-Rad, Medtronic - GlobeNewswire
Bio-Rad Launches EZ-Check Salmonella spp. Kit for Detection of Salmonella spp. in Food and Environmental Samples - Quality Assurance & Food Safety
We Think Bio-Rad Laboratories (NYSE:BIO) Can Stay On Top Of Its Debt - 富途牛牛
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap DownTime to Sell? - MarketBeat
Analyzing Bio Rad Laboratories Inc. with multi timeframe chartsJuly 2025 Patterns & Fast Moving Trade Plans - newser.com
Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap Down – Time to Sell? - Defense World
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Reduces Holdings in Bio-Rad Laboratories, Inc. $BIO - Defense World
Jacobs Levy Equity Management Inc. Purchases New Position in Bio-Rad Laboratories, Inc. $BIO - Defense World
Select Equity Group L.P. Lowers Stock Position in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Millennium Management LLC Sells 41,025 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Petrus Trust Company LTA Has $688,000 Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Protein Purification & Isolation Market Set for Significant - openPR.com
Protein Detection and Quantification Market Fueled by 9.6% CAGR - openPR.com
Flow Cytometry Market to Reach $11.34B by 2033, Growing at 7.5% - openPR.com
Bio-Rad Laboratories, Inc. $BIO Shares Sold by Perbak Capital Partners LLP - MarketBeat
The Manufacturers Life Insurance Company Purchases 6,807 Shares of Bio-Rad Laboratories, Inc. $BIO - MarketBeat
What candlestick patterns are forming on Bio Rad Laboratories Inc.Market Activity Summary & Technical Pattern Based Buy Signals - Newser
Analyzing drawdowns of Bio Rad Laboratories Inc. with statistical toolsStop Loss & Accurate Entry/Exit Alerts - Newser
Options Data Show Bullish Bias in Bio Rad Laboratories Inc.Earnings Miss & Free Safe Entry Trade Signal Reports - beatles.ru
What earnings revisions data tells us about Bio Rad Laboratories Inc.2025 Historical Comparison & Long-Term Capital Growth Strategies - Newser
Bio-Rad Tries to Smother Ex-GC's Whistleblower Suit With Privilege Claims - Law.com
Wellington Management Group LLP Increases Stock Holdings in Bio-Rad Laboratories, Inc. $BIO - MarketBeat
Heatmap analysis for Bio Rad Laboratories Inc. and competitors2025 Market Outlook & Low Drawdown Momentum Trade Ideas - Newser
How liquid is Bio Rad Laboratories Inc. stockPortfolio Gains Report & Advanced Technical Analysis Signals - خودرو بانک
New Product Launches: Will They Boost Bio Rad Laboratories Inc. Stock in 2025Market Performance Summary & Capital Protection Trade Alerts - Newser
Bio-Rad Laboratories, Inc. $BIO Shares Sold by Comerica Bank - MarketBeat
What high frequency data says about Bio Rad Laboratories Inc.2025 Trading Volume Trends & Accurate Entry/Exit Alerts - Newser
Bio Rad Laboratories Inc Stock (BIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
Bio Rad Laboratories Inc Stock (BIO) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Lakkaraju Roop Kalyan | EVP, Chief Financial Officer |
Sep 06 '25 |
Option Exercise |
0.00 |
1,535 |
0 |
2,394 |
| COREY COLLEEN | EVP, Global Human Resources |
Sep 06 '25 |
Option Exercise |
0.00 |
576 |
0 |
19,759 |
| BARRY JAMES | EVP, President, LSG |
Sep 06 '25 |
Option Exercise |
0.00 |
1,056 |
0 |
1,588 |
| Allison Schwartz | Director |
Sep 06 '25 |
Option Exercise |
0.00 |
92 |
0 |
1,489 |
| ENGELHARDT EVA ANETTE | EVP, President, CDG |
Sep 06 '25 |
Option Exercise |
0.00 |
1,152 |
0 |
1,309 |
| ENLOE COURTNEY C | EVP, General Counsel & Sec |
Sep 06 '25 |
Option Exercise |
0.00 |
768 |
0 |
904 |
| SCHWARTZ NORMAN D | Chairman & CEO |
Sep 06 '25 |
Option Exercise |
0.00 |
3,455 |
0 |
444,962 |
| Allison Schwartz | Director |
Sep 01 '25 |
Option Exercise |
0.00 |
147 |
0 |
1,452 |
| BARRY JAMES | EVP, President, LSG |
Sep 01 '25 |
Option Exercise |
0.00 |
602 |
0 |
749 |
| COREY COLLEEN | EVP, Global Human Resources |
Sep 01 '25 |
Option Exercise |
0.00 |
1,102 |
0 |
19,581 |
3.50%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):